NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
Clinical trial NCT07365930 · RECRUITING
Trial details
- NCT number
- NCT07365930
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-17
- Primary completion
- 2031-12-17
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.